The CONTRAST-NP Study for Chronic
Rhinosinusitis with Nasal Polyps
Adults who have Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Adults who have Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
—The CONTRAST-NP research study is enrolling!
See if you qualify
No health insurance
or referrals needed.
Those who qualify may receive:
- Study-related care at no cost from local doctors
- Study medication at no cost
Take the next step to see if you qualify for this study. But don’t delay — space is limited!
Why is the CONTRAST-NP study on Chronic Rhinosinusitis with Nasal Polyps so important?
Quality of life is a serious issue for people who have Chronic Rhinosinusitis with Nasal Polyps. In fact, a recent survey found that the condition affects many parts of people’s lives, including their sleep. This can lead to fatigue (feeling tired), which can make it hard to focus and impact a person’s ability to work or socialize.
What others don’t realize, too, is just how painful facial pressure and headaches can be when nasal passages are swollen — and polyps (benign/non-cancerous growths) add to the pain and discomfort, making it even harder to breathe. These blocked or clogged passages can also result in sore throats (from postnasal drip) and sinus infections, which can turn serious.
This study is assessing an investigational medication to see if it can reduce symptoms like nasal congestion (stuffy nose). It works by blocking certain kinds of inflammation-causing cells. Reducing inflammation (or swelling) is key, because it can cause the formation of polyps as well as block nasal passages.
If you choose to enroll and qualify, you are free to leave the study any time after enrolling. Act now to see if you qualify!
How does it work?
Answer some questions about your health
Tell us a little bit about yourself
Connect to available studies in your area
Just takes a few minutes
AcurianHealth helps connect people with research studies that offer treatment under development.
Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.
*In a research study, the participants may receive investigational study medication or an inactive substance (placebo) depending on the study design.
Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.
©2023 Acurian, Inc. All rights reserved.